의료용 홀로그래픽 디스플레이 : 시장 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the medical holographic display market size is expected to grow from USD 265.93 million in 2025 to USD 330.07 million in 2026 and is forecast to reach USD 972.38 million by 2031 at 24.12% CAGR over 2026-2031.

This report is Segmented by Product Type (Volumetric 3-D Display, and More), Application (Medical Imaging & Radiology, Biomedical Research, Medical Education & Training, Others), End User (Hospitals & Surgical Centres, and More), and Geography (North America, Europe, Asia-Pacific, Rest of the World). The Market Forecasts are Provided in Terms of Value (USD).

Global Medical Holographic Display Market Trends and Insights

Growing Adoption of Minimally Invasive & Image-Guided Surgery

Minimally invasive surgery volumes are expanding at 16.8% CAGR, yet conversion to open procedures persists when 2-D monitors obscure depth cues. Robot-assisted systems now achieve up to 99.7% pedicle-screw accuracy, greatly surpassing conventional fluoroscopy. GE Healthcare's OmnifyXR overlay, deployed in Minneapolis in June 2024, lets interventional radiologists view catheter trajectories in native 3-D without switching workstations. The da Vinci 5 platform integrates holographic guidance as a built-in feature, illustrating how OEMs perceive immersive visualization as a competitive moat. HoloCare's roll-out in U.K. and Norwegian university hospitals cut alignment time by 74%, translating into shorter anesthesia exposure and higher operating-room throughput.

Increasing Prevalence of Chronic Diseases Requiring Advanced 3-D Visualization

The WHO recorded 20 million new cancer diagnoses in 2024, with a rise to 35 million expected by 2050. Oncology and cardiology now depend on volumetric imaging modalities whose depth complexity overwhelms flat-panel displays. Holography reduces radiation-therapy contouring errors by up to 20%, improving organ-at-risk sparing. In a laparoscopic ablation study, Apple Vision Pro integration lifted procedural success from 42.5% to 90%. Pharmaceutical researchers visualize molecular binding pockets in full 3-D, accelerating lead-compound identification relative to 2-D modeling workflows.

High Capital & Maintenance Cost of Holographic Workstations

Systems priced between USD 80,000 and USD 250,000 eclipse budgets of ambulatory centers whose operating margins trail hospital averages by 20-30%. Annual maintenance contracts add 12-15%, covering calibration and GPU upgrades. Absence of CPT codes for holography-assisted surgery prevents fee recoupment. Academic hospitals often leverage grants rather than operating cash, a path impractical for 6,000-plus U.S. facilities. Vendors must prove that cutting 10 minutes of OR time (valued at USD 15-30 per minute) yields credible ROI before widespread procurement.

Other drivers and restraints analyzed in the detailed report include:

1. Rapid Advances in Light-Field & Volumetric Display Components
2. Integration with MR-Guided Robotic Surgery Platforms
3. Regulatory & Data-Governance Hurdles for 3-D Patient Data

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Volumetric 3-D displays held 39.43% of 2025 revenue, reflecting maturity in multi-viewer collaboration. Laser plasma displays, though second in adoption, are forecast for 25.10% CAGR, making them the fastest-growing component of the medical holographic display market. Their screen-less mid-air voxels prevent sterile-field breaches, a decisive benefit for operating rooms. Light-field systems, powered by Leia Inc.'s diffractive backlighting, offer a cost-efficient path using consumer LCD supply chains. The "Others" cluster-digital holographic microscopy and AR headsets-serves pathology and ophthalmology niches.

Thermal dissipation and IEC 60825 eye-safety hurdles cloud laser plasma's outlook, yet vendors push refresh rates toward 60 Hz to meet surgical tracking demands. Light-field platforms slash component prices 20% per year, but angular resolution still lags volumetric peers. Because FDA clearances hinge on application rather than optics, suppliers iterate hardware without new submissions, accelerating cycle times. Continuous innovation ensures that the medical holographic display market remains product-type agnostic in regulatory eyes while clinical buyers weigh image fidelity and sterility as decisive factors.

Complete Report Scope:

• By Product Type
  • Volumetric 3-D Display
  • Light-Field Display
  • Laser Plasma Display
  • Others
• By Application
  • Medical Imaging & Radiology
  • Biomedical Research
  • Medical Education & Training
  • Others
• By End User
  • Hospitals & Surgical Centres
  • Diagnostic Imaging Centres
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Rest of the World

Geography Analysis

North America controlled 45.15% of 2025 revenue, propelled by the United States' dense network of academic medical centers and a mature 510(k) approval pathway. The da Vinci 5 and GE OmnifyXR launches illustrate entrenched OEM dominance in the region. Canada trails, demanding rigorous cost-effectiveness evidence prior to procurement, while Mexico's private chains pilot holography in oncology centers amid reimbursement gaps.

Asia-Pacific is projected to log the highest 25.19% CAGR, expanding the medical holographic display market size most rapidly through 2031. China's AI-in-healthcare mandates, Japan's accelerated Sakigake pathway, and India's corporate-hospital expansion fuel momentum. Domestic Chinese vendors undercut Western peers by 30-40%, democratizing access. Japan's Holoeyes platform enjoys PMDA backing and broad university deployment, whereas India's Apollo and Fortis chains test systems in neurosurgery suites. South Korea and Australia advance through academic pilots, pending insurer reimbursement decisions.

Europe captures mid-tier share, led by Germany, the United Kingdom, and France, where public research funds catalyze adoption. HoloCare's CE-marked deployments in Leeds and Oslo cut alignment time by 74%, directly answering DRG incentives that reward length-of-stay reductions. The stringent European MDR elongates approvals but ensures safety rigor. Rest-of-World regions-including Latin America, the Middle East, and Africa-remain niche, with uptake in private medical-tourism hospitals and grant-funded academic centers.

1. BrighterWave AB
2. Dimension Technologies Inc.
3. EchoPixel Inc.
4. EON Reality
5. Holografika Kft.
6. Holoxica Limited
7. LightSpace Technologies
8. Looking Glass Factory Inc.
9. Lynx Mixed Reality
10. MDH Hologram
11. Ovizio Imaging Systems
12. Realfiction Holding A/S
13. RealView Imaging Ltd.
14. VividQ Ltd.
15. Voxon Photonics
16. WayRay AG
17. zSpace

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing adoption of minimally invasive & image-guided surgery
  • 4.2.2 Increasing prevalence of chronic diseases requiring advanced 3-D visualisation
  • 4.2.3 Rapid advances in light-field & volumetric display components
  • 4.2.4 Integration with MR-guided robotic surgery platforms
  • 4.2.5 Falling cost of GPU-photonics enabling point-of-care holography
  • 4.2.6 Surge in medical-metaverse R&D funding by pharma OEMs
• 4.3 Market Restraints
  • 4.3.1 High capital & maintenance cost of holographic workstations
  • 4.3.2 Regulatory & data-governance hurdles for 3-D patient data
  • 4.3.3 Visual-fatigue and cybersickness limiting continuous clinical use
  • 4.3.4 Lack of DICOM extensions for holographic datasets
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product Type
  • 5.1.1 Volumetric 3-D Display
  • 5.1.2 Light-Field Display
  • 5.1.3 Laser Plasma Display
  • 5.1.4 Others
• 5.2 By Application
  • 5.2.1 Medical Imaging & Radiology
  • 5.2.2 Biomedical Research
  • 5.2.3 Medical Education & Training
  • 5.2.4 Others
• 5.3 By End User
  • 5.3.1 Hospitals & Surgical Centres
  • 5.3.2 Diagnostic Imaging Centres
  • 5.3.3 Academic & Research Institutes
  • 5.3.4 Pharmaceutical & Biotechnology Companies
• 5.4 By Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 South Korea
    • 5.4.3.5 Australia
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Rest of the World

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 BrighterWave AB
  • 6.3.2 Dimension Technologies Inc.
  • 6.3.3 EchoPixel Inc.
  • 6.3.4 EON Reality Inc.
  • 6.3.5 Holografika Kft.
  • 6.3.6 Holoxica Limited
  • 6.3.7 LightSpace Technologies
  • 6.3.8 Looking Glass Factory Inc.
  • 6.3.9 Lynx Mixed Reality
  • 6.3.10 MDH Hologram
  • 6.3.11 Ovizio Imaging Systems
  • 6.3.12 Realfiction Holding A/S
  • 6.3.13 RealView Imaging Ltd.
  • 6.3.14 VividQ Ltd.
  • 6.3.15 Voxon Photonics
  • 6.3.16 WayRay AG
  • 6.3.17 zSpace Inc.

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-Need Assessment